• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人群股浅动脉和腘动脉镍钛合金支架置入后的结局

Outcome after nitinol stenting in the superficial femoral and popliteal artery in an elderly population.

作者信息

Gillgren Peter, Pettersson Hans, Fernström Johan, Falkenberg Mårten, Delle Martin, Konrad Peter, Lindström David

机构信息

Vascular Surgery Section, Department of Clinical Science and Education, Karolinska Institute, Stockholm, Sweden.

出版信息

Ann Vasc Surg. 2011 Aug;25(6):758-65. doi: 10.1016/j.avsg.2010.12.010. Epub 2011 Mar 25.

DOI:10.1016/j.avsg.2010.12.010
PMID:21439769
Abstract

BACKGROUND

To assess outcomes in an elderly and diseased population after stenting in the femoropopliteal segment and evaluate risk factors for poor prognosis.

METHODS

Retrospective study of femoropopliteal stents placed between March 2006 and January 2008. Patency was verified by duplex scanning. Risk factors associated with amputation or death and patency were analyzed using Cox regression.

RESULTS

A total of 117 limbs in 112 patients were observed for a median of 18 months. Median age of the patients was 79 years; 68% were treated for critical limb ischemia and 85% had occlusive lesions. Mean lesion length was 15.4 cm (SD: 9.2) and mean stented length was 19.7 cm (standard deviation: 9.8). At 1 year, primary patency was 63%, primary-assisted patency was 67%, and secondary patency was 69%. Stent diameter ≤6 versus 7 mm was a risk factor for loss of patency with a hazard ratio (HR) of 2.9 (95% CI: 1.1-7.7). Significant risk factors for death or amputation were as follows: HR for rest pain versus claudication was 5.9 (1.1-32.8), HR for tissue loss versus claudication was 5.8 (1.1-29.6), HR for stent diameter ≤6 versus 7 mm was 3.6 (1.0-12.3), and HR for 3-4 stents versus 1-2 was 2.6 (1.1-6.1).

CONCLUSION

Rutherford status is associated with death or amputation after stenting in the femoropopliteal segment. In addition, a smaller stent diameter and number of stents depict poorer prognosis independent of gender and anatomic level.

摘要

背景

评估老年及患病群体在股腘段支架置入术后的结局,并评估预后不良的危险因素。

方法

对2006年3月至2008年1月期间置入的股腘段支架进行回顾性研究。通过双功超声扫描验证通畅情况。使用Cox回归分析与截肢或死亡以及通畅相关的危险因素。

结果

共观察了112例患者的117条肢体,中位观察时间为18个月。患者的中位年龄为79岁;68%的患者因严重肢体缺血接受治疗,85%有闭塞性病变。平均病变长度为15.4 cm(标准差:9.2),平均支架置入长度为19.7 cm(标准差:9.8)。1年时,原发性通畅率为63%,原发性辅助通畅率为67%,继发性通畅率为69%。支架直径≤6 mm与7 mm相比是通畅丧失的危险因素,风险比(HR)为2.9(95%可信区间:1.1 - 7.7)。死亡或截肢的显著危险因素如下:静息痛与间歇性跛行相比的HR为5.9(1.1 - 32.8),组织缺失与间歇性跛行相比的HR为5.8(1.1 - 29.6),支架直径≤6 mm与7 mm相比的HR为3.6(1.0 - 12.3),3 - 4个支架与1 - 2个支架相比的HR为2.6(1.1 - 6.1)。

结论

Rutherford分级与股腘段支架置入术后的死亡或截肢相关。此外,较小的支架直径和支架数量表明预后较差,与性别和解剖水平无关。

相似文献

1
Outcome after nitinol stenting in the superficial femoral and popliteal artery in an elderly population.老年人群股浅动脉和腘动脉镍钛合金支架置入后的结局
Ann Vasc Surg. 2011 Aug;25(6):758-65. doi: 10.1016/j.avsg.2010.12.010. Epub 2011 Mar 25.
2
Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.股腘动脉自膨式镍钛合金支架置入术后中期临床结果及血管通畅性的预测因素。
J Vasc Surg. 2010 Sep;52(3):608-15. doi: 10.1016/j.jvs.2010.03.050. Epub 2010 Jun 22.
3
Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.紫杉醇药物洗脱裸金属支架(Zilver PTX)治疗股腘动脉闭塞性疾病的真实世界疗效
Ann Vasc Surg. 2017 Jan;38:90-98. doi: 10.1016/j.avsg.2016.08.006. Epub 2016 Aug 20.
4
PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.PEACE I 所有受试者注册研究:4 法国规格的 Pulsar-18 自膨式镍钛合金支架植入股腘动脉病变后的通畅性评估
J Endovasc Ther. 2014 Jun;21(3):373-80. doi: 10.1583/13-4637R.1.
5
Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.经皮 ePTFE/镍钛诺自膨式支架移植物与人工股腘旁路术治疗股浅动脉闭塞性疾病的 4 年随机前瞻性比较。
J Vasc Surg. 2010 Sep;52(3):584-90; discussion 590-1, 591.e1-591.e7. doi: 10.1016/j.jvs.2010.03.071.
6
Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery.基于临床和病变因素的新型分类在股浅动脉自膨式镍钛合金支架置入术后的应用。
J Vasc Surg. 2011 Oct;54(4):1058-66. doi: 10.1016/j.jvs.2011.03.286. Epub 2011 Aug 31.
7
Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.ePTFE/镍钛诺自膨式覆膜支架与人工股腘动脉旁路移植术治疗股浅动脉闭塞性疾病的随机对照研究
J Vasc Surg. 2009 Jan;49(1):109-15, 116.e1-9; discussion 116. doi: 10.1016/j.jvs.2008.08.041. Epub 2008 Nov 22.
8
Primary stenting of the superficial femoral and popliteal artery.股浅动脉和腘动脉的初次支架置入术。
J Vasc Surg. 2009 Sep;50(3):542-7. doi: 10.1016/j.jvs.2009.04.019. Epub 2009 Jun 21.
9
Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.镍钛诺支架植入术与球囊血管成形术治疗间歇性跛行患者股浅动脉和腘动脉近段病变:RESILIENT 随机试验 3 年随访结果。
J Endovasc Ther. 2012 Feb;19(1):1-9. doi: 10.1583/11-3627.1.
10
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.使用螺旋编织镍钛诺支架治疗股腘动脉闭塞性疾病时再狭窄的预测因素。
J Vasc Surg. 2015 Nov;62(5):1201-9. doi: 10.1016/j.jvs.2015.05.030. Epub 2015 Jul 11.